Ohio Public Employees Retirement System (OPERS)’s Inovio Pharmaceuticals INO Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,036	Closed	-$421K	–	2028
2021 Q4	$421K	Hold	7,036	–	–	﹤0.01%	1364
2021 Q3	$605K	Hold	7,036	–	–	﹤0.01%	1321
2021 Q2	$783K	Hold	7,036	–	–	﹤0.01%	1285
2021 Q1	$784K	Sell	7,036 -603	-8%	-$79.3K	﹤0.01%	1264
2020 Q4	$811K	Hold	7,639	–	–	﹤0.01%	1213
2020 Q3	$1.06M	Buy	7,639 +3,580	+88%	+$746K	0.01%	1082
2020 Q2	$1.31M	Sell	4,059 -3,618	-47%	-$581K	0.01%	1067
2020 Q1	$685K	Sell	7,677 -9,410	-55%	-$580K	﹤0.01%	1128
2019 Q4	$677K	Hold	17,087	–	–	﹤0.01%	1217
2019 Q3	$420K	Hold	17,087	–	–	﹤0.01%	1355
2019 Q2	$603K	Sell	17,087 -1,643	-9%	-$65.3K	﹤0.01%	1299
2019 Q1	$838K	Hold	18,730	–	–	﹤0.01%	1258
2018 Q4	$899K	Buy	18,730 +2,428	+15%	+$147K	0.01%	1160
2018 Q3	$1.09M	Buy	16,302 +8,202	+101%	+$457K	0.01%	1233
2018 Q2	$381K	Hold	8,100	–	–	﹤0.01%	1454
2018 Q1	$458K	Sell	8,100 -765	-9%	-$41.4K	﹤0.01%	1404
2017 Q4	$439K	Hold	8,865	–	–	﹤0.01%	1401
2017 Q3	$674K	Hold	8,865	–	–	﹤0.01%	1319
2017 Q2	$834K	Buy	8,865 +4,158	+88%	+$356K	﹤0.01%	1253
2017 Q1	$374K	Hold	4,707	–	–	﹤0.01%	1385
2016 Q4	$373K	Hold	4,707	–	–	﹤0.01%	1390
2016 Q3	$526K	Hold	4,707	–	–	﹤0.01%	1285
2016 Q2	$522K	Hold	4,707	–	–	﹤0.01%	1248
2016 Q1	$492K	Sell	4,707 -354	-7%	-$27.3K	﹤0.01%	1237
2015 Q4	$408K	Hold	5,061	–	–	﹤0.01%	1290
2015 Q3	$351K	Hold	5,061	–	–	﹤0.01%	1353
2015 Q2	$496K	Hold	5,061	–	–	﹤0.01%	1302
2015 Q1	$496K	Hold	5,061	–	–	﹤0.01%	1281
2014 Q4	$558K	Buy	+5,061	New	+$618K	﹤0.01%	1293

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s INO Position: Q1 2022 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Inovio Pharmaceuticals (INO) in Q1 2022, closing a stake of 7,036 shares — an estimated $421K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in INO in Q4 2014 and held it in 29 quarters. The position peaked at $1.31M in Q2 2020. 198 funds tracked by Wall St. Rank hold INO as of Q1 2022.

Ohio Public Employees Retirement System (OPERS) reported no remaining Inovio Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Ohio Public Employees Retirement System (OPERS) sold 7,036 Inovio Pharmaceuticals shares in Q1 2022, an estimated $421K.
Ohio Public Employees Retirement System (OPERS) first reported a position in Inovio Pharmaceuticals in Q4 2014 and held it in 29 quarters.
Ohio Public Employees Retirement System (OPERS)'s Inovio Pharmaceuticals position peaked at $1.31M in Q2 2020.
198 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2022.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2022, filed 16 May 2022.